These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 4980529)

  • 1. 6-hydroxylated N,N-dimethyltryptamines and hallucinogenic potency.
    Uyeno ET
    Proc West Pharmacol Soc; 1969; 12():118-23. PubMed ID: 4980529
    [No Abstract]   [Full Text] [Related]  

  • 2. Alteration of a learned response of the squirrel monkey by hallucinogens.
    Uyeno ET
    Int J Neuropharmacol; 1969 May; 8(3):245-53. PubMed ID: 4978723
    [No Abstract]   [Full Text] [Related]  

  • 3. A quantum chemical investigation of the pi-electronic structure of the hallucinogenic N,N-dimethyltryptamines.
    Glennon RA
    Res Commun Chem Pathol Pharmacol; 1974 Sep; 9(1):185-8. PubMed ID: 4531086
    [No Abstract]   [Full Text] [Related]  

  • 4. Progress with several models for the study of the SAR of hallucinogenic agents.
    Kier LB; Glennon RA
    NIDA Res Monogr; 1978; (22):159-85. PubMed ID: 101879
    [No Abstract]   [Full Text] [Related]  

  • 5. Self-association and binding sites of some psychotomimetic tryptamine derivatives and related compounds: nuclear magnetic resonance investigations.
    Sapper H; Lohmann W
    Mol Pharmacol; 1976 Jul; 12(4):605-11. PubMed ID: 958209
    [No Abstract]   [Full Text] [Related]  

  • 6. The hallucinogenic world of tryptamines: an updated review.
    Araújo AM; Carvalho F; Bastos Mde L; Guedes de Pinho P; Carvalho M
    Arch Toxicol; 2015 Aug; 89(8):1151-73. PubMed ID: 25877327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of a hallucinogen, 5-methoxy N,N-dimethyltryptamine, on primate social behavior.
    Schlemmer RF; Narasimhachari N; Thompson VD; Davis JM
    Commun Psychopharmacol; 1977; 1(2):105-18. PubMed ID: 414877
    [No Abstract]   [Full Text] [Related]  

  • 8. Hallucinogenic drugs of the indolealkylamine type and central monoamine neurons.
    Andén NE; Corrodi H; Fuxe K
    J Pharmacol Exp Ther; 1971 Nov; 179(2):236-49. PubMed ID: 5133600
    [No Abstract]   [Full Text] [Related]  

  • 9. DOM (STP), a new hallucinogenic drug, and DOET: effects in normal subjects.
    Snyder SH; Faillace LA; Weingartner H
    Am J Psychiatry; 1968 Sep; 125(3):113-20. PubMed ID: 4385937
    [No Abstract]   [Full Text] [Related]  

  • 10. Structure-activity relationships for hallucinogenic N,N-dialkyltryptamines: photoelectron spectra and serotonin receptor affinities of methylthio and methylenedioxy derivatives.
    Kline TB; Benington F; Morin RD; Beaton JM; Glennon RA; Domelsmith LN; Houk KN; Rozeboom MD
    J Med Chem; 1982 Nov; 25(11):1381-3. PubMed ID: 6815326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacology of hallucinogens].
    Waser PG
    Schweiz Rundsch Med Prax; 1971 Jul; 60(30):1001-5. PubMed ID: 4327477
    [No Abstract]   [Full Text] [Related]  

  • 12. Structure-activity relationships among hallucinogenic tryptamine derivatives evaluated by schedule-controlled behaviour.
    Harris RA; Homfeld E; Campaigne E
    J Pharm Pharmacol; 1981 May; 33(5):320-2. PubMed ID: 6116783
    [No Abstract]   [Full Text] [Related]  

  • 13. 5-methoxy-N, N-dimethyltryptamine, a possible endogenous psychotoxin.
    Benington F; Morin RD; Clark LC
    Ala J Med Sci; 1965 Oct; 2(4):397-403. PubMed ID: 5892656
    [No Abstract]   [Full Text] [Related]  

  • 14. Speculations on the mechanism of action of hallucinogenic indolealkylamines.
    Glennon RA; Rosecrans JA
    Neurosci Biobehav Rev; 1981; 5(2):197-207. PubMed ID: 7022271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The comparative behavioral effects of N,N-dimethyltryptamine and N,N-diethyltryptamine in primate dyads.
    Heinze WJ; Schlemmer RF; Tyler CB; Davis JM
    Biol Psychiatry; 1983 Jul; 18(7):829-36. PubMed ID: 6577915
    [No Abstract]   [Full Text] [Related]  

  • 16. Psychotomimetic N-methyl-N-isopropyltryptamines. Effects of variation of aromatic oxygen substituents.
    Repke DB; Grotjahn DB; Shulgin AT
    J Med Chem; 1985 Jul; 28(7):892-6. PubMed ID: 4009612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral effects of N,N-dimethyltryptamine in rats and mice.
    Moussatché H; Carlini EA; dos Santos M
    Rev Bras Biol; 1970 Dec; 30(4):483-9. PubMed ID: 5535408
    [No Abstract]   [Full Text] [Related]  

  • 18. Alpha-methyltryptamine revisited via easy Internet access.
    Long H; Nelson LS; Hoffman RS
    Vet Hum Toxicol; 2003 Jun; 45(3):149. PubMed ID: 12776793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hallucinogens in Drug Discrimination.
    Baker LE
    Curr Top Behav Neurosci; 2018; 36():201-219. PubMed ID: 28484970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between chemical structure and pharmacological activity in a series of 5-alkoxy substitution derivatives of tryptamine.
    Arutyunyan GS; Mashkovskii MD; Roshchina LF
    Fed Proc Transl Suppl; 1965; 24(6):1108-10. PubMed ID: 5215181
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.